About this trial
The objective of this study is to test the idea that Pulsed Electromagnetic Field (PEMF) therapy will serve as a safe therapeutic modality that can effectively be administered simultaneously with bladder instillations of a bupivacaine-heparin cocktail to improve the chronic pain and/or associated symptoms of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) patients. The study team will distribute the PEMF device to female adults with IC/BPS who have been prescribed bladder instillations of bupivacaine-heparin to see if PEMF therapy in conjunction with bladder instillations of heparin and bupivacaine may be more effective in reducing pain levels and symptomatology of IC/BPS than instillations alone.
Eligibility criteria
Qualifiers
Previously established clinical diagnosis of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
Current Numeric Rating Scale (NRS) greater than or equal to 5
History of cystoscopy with hydrodistension with bladder capacity determination under anesthesia
No contraindications to the instillation solution
Disqualifiers
History of bladder, ovarian or vaginal cancer
History of urethral diverticulum
History of radiation cystitis
History of spinal cord injury or spina bifida
Trial design
Treatments tested in this trial
- Pulsed Electromagnetic Field (PEMF) Device
- Sham Pulsed Electromagnetic Feild (PEMF) Device